|
|
Article: Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke.
- Article from:
- Business Wire
- Article date:
- June 24, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Trial Uses Reveal XT Insertable Cardiac Monitor to Assess Incidence of Atrial Fibrillation in Patients Who Have Suffered a Stroke of Unknown Origin
Separate Trial to Compare Intrathecal Baclofen Therapy to Conventional Treatments in the Management of Severe Post-Stroke Spasticity
MINNEAPOLIS & BERLIN -- Each year, approximately 795,000 people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted2. Today, Medtronic, Inc. (NYSE: MDT) announces two significant clinical trials related to medical device interventions for stroke. First enrollments in the global CRYSTAL AF ...